Consensus Lupin Limited

Stocks

LUPIN

INE326A01037

Pharmaceuticals

Market Closed - Bombay S.E. 06:29:37 2026-10-22 EDT			5-day change	1st Jan Change
1,928.00 ^INR	-1.48%		-1.59%	-8.71%

09-04	Lupin Limited Receives U.S. FDA Approval For Modafinil Tablets USP 100 Mg And 200 Mg	CI
08-28	Lupin Assigned ESG rating by Crisil ESG Ratings & Analytics	MT

Evolution of the Average Target: Lupin Limited

Evolution of the Target Price: Lupin Limited

Changes in Analyst Recommendations: Lupin Limited

0ac5e2341f771eb29cf5155a.l3J2y9l7kEZR1Nisap6PjwqbMzuJhmgmpRCH4qeVvIc.zhkbnpwp4AtllYHBJavF9Wj2BBa-wBJM1iD0qunNjf2mRT6JqR7TBzfsjQ~200d105879300f45856f9da763587d03

Analysts' recommendations: Lupin Limited

05-13	Nomura Adjusts Lupin's Price Target to INR2,675 From INR2,580, Keeps at Buy	MT
05-11	Emkay Global Downgrades Lupin to Add from Buy; Price Target is INR2,500	MT
05-11	Phillip Securities Downgrades Lupin to Neutral from Buy; Price Target is INR2,420	MT
05-11	JM Financial Downgrades Lupin to Sell from Reduce; Price Target is INR1,992	MT
05-11	Jefferies Downgrades Lupin to Underperform from Buy, Adjusts Price Target to INR2,020 from INR2,540	MT
02-16	Jefferies Adjusts Lupin's Price Target to INR2,540 From INR2,430, Keeps at Buy	MT
11-11	Nomura Adjusts Lupin's Price Target to INR2,580 From INR2,350, Keeps at Buy	MT
11-10	Jefferies Adjusts Lupin's Price Target to INR2,300 From INR2,250, Keeps at Buy	MT
11-10	Avendus Spark Upgrades Lupin to Buy from Add; Price Target is INR2,270	MT
25-08-07	Jefferies Upgrades Lupin to Buy From Hold, Adjusts Price Target to INR2,250 From INR2,200	MT
25-02-13	Jefferies Adjusts Lupin's Price Target to INR2,200 From INR2,400, Keeps at Hold	MT
25-02-13	Nomura Adjusts Lupin's Price Target to INR2,350 From INR2,490, Keeps at Buy	MT
24-11-11	Jefferies Adjusts Lupin's Price Target to INR2,070 From INR1,900, Keeps at Hold	MT
24-11-11	Nomura Adjusts Lupin's Price Target to INR2,490 From INR2,427, Keeps at Buy	MT
24-11-11	Nomura Adjusts Lupin's Price Target to INR2,490 From INR2,427, Keeps at Buy	MT
24-08-30	Nomura Adjusts Lupin's Price Target to INR2,427 From INR1,952, Keeps at Buy	MT
24-08-08	Jefferies Adjusts Lupin's Price Target to INR1,900 From INR1,535, Keeps at Hold	MT
24-05-09	Nomura Adjusts Lupin’s Price Target to INR1,952 From INR1,949, Keeps at Buy	MT
24-05-08	Jefferies Adjusts Lupin’s Price Target to INR1,535 From INR1,460 Keeps at Hold	MT
24-02-09	Jefferies Upgrades Lupin to Hold From Underperform, Adjusts Price Target to INR430 From INR520	MT
24-01-02	Nomura Adjusts Lupin's Price Target to INR1,593 From INR1,290, Keeps at Buy	MT
23-08-08	Nomura Adjusts Lupin’s Price Target to INR1,290 From INR977, Keeps at Buy	MT
23-08-07	Jefferies Adjusts Lupin’s Price Target to INR810 From INR660, Keeps at Underperform	MT
23-06-26	Nomura Adjusts Lupin's Price Target to INR977 From INR861, Keeps at Buy	MT
23-05-12	Nomura Adjusts Lupin's Price Target to INR861 From INR856, Keeps at Buy	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LUPIN LIMITED					+24.99%
	ELI LILLY AND COMPANY					+4.78%
	JOHNSON & JOHNSON					+8.39%
	ABBVIE INC.					-0.46%
	ROCHE HOLDING AG					-2.05%
	MERCK & CO., INC.					+5.79%
	NOVARTIS AG					-2.49%
	ASTRAZENECA PLC					+24.34%
	AMGEN INC.					-9.73%
	GILEAD SCIENCES, INC.					+4.29%
	Average					+5.79%
	Weighted average by Cap.					+4.04%